Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers DOI Creative Commons

Xiujin Zhang,

Zhiqing Fu, Haijun Wang

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 20, 2024

Pulmonary hypertension (PH) can lead to right ventricular hypertrophy, significantly increasing mortality rates. This study aims clarify PH-specific metabolites and their impact on genomic post-translational modifications (PTMs) in cancer, evaluating DHA EPA's therapeutic potential mitigate oxidative stress inflammation.

Язык: Английский

The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer DOI Creative Commons

Qiu Li,

Shourong Wu, Lei Zhang

и другие.

Genes & Diseases, Год журнала: 2025, Номер unknown, С. 101567 - 101567

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0
N6-methyladenosine promotes aberrant redox homeostasis required for arsenic carcinogenesis by controlling the adaptation of key antioxidant enzymes DOI
Tianhe Zhao, Donglei Sun,

Keyan Long

и другие.

Journal of Hazardous Materials, Год журнала: 2023, Номер 465, С. 133329 - 133329

Опубликована: Дек. 22, 2023

Язык: Английский

Процитировано

9
Exercise-induced redox modulation as a mediator of DNA methylation in health maintenance and disease prevention DOI
Daniela Caporossi, Ivan Dimauro

Free Radical Biology and Medicine, Год журнала: 2024, Номер 213, С. 113 - 122

Опубликована: Янв. 17, 2024

Язык: Английский

Процитировано

0
Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers DOI Creative Commons

Xiujin Zhang,

Zhiqing Fu, Haijun Wang

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Ноя. 20, 2024

Pulmonary hypertension (PH) can lead to right ventricular hypertrophy, significantly increasing mortality rates. This study aims clarify PH-specific metabolites and their impact on genomic post-translational modifications (PTMs) in cancer, evaluating DHA EPA's therapeutic potential mitigate oxidative stress inflammation.

Язык: Английский

Процитировано

0